Halozyme Therapeutics

HALO

HALO
Halozyme Therapeutics Stock Quote
$15.74 -$0.16 -1.0%
BATS BZX Real Time Price as of October 16, 2019, 3:56 p.m. EDT View Interactive HALO Charts

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

News & Analysis: Halozyme Therapeutics

The Fool has written over 100 articles on Halozyme Therapeutics.

All

Market Moves

Earnings








3 Monster Stocks in the Making

Halozyme Therapeutics, FMC Corp., and Braskem all have major opportunities in front of them that could lead to outsize returns.




Interactive Chart